Colony »

Prelude Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Colony from 13F filings

Historical chart of Colony investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2025-12-31 $145k 50k 2.90

More positions owned by Colony

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr State Street Tec (XLK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Vanguard World Inf Tech Etf (VGT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Colony

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Vanguard Group
Millennium Management
Kynam Capital Management
Acadian Asset Management
Marshall Wace
Geode Capital Management
Renaissance Technologies
BlackRock
Two Sigma Advisers
Susquehanna International
TD Asset Management
Two Sigma Investments
State Street Corporation

View all funds holding Prelude Therapeutics